1. Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report.
- Author
-
de Souto Barreto P, Cesari M, Morley JE, Roberts S, Landi F, Cederholm T, Rolland Y, Vellas B, and Fielding R
- Subjects
- Aged, Aging psychology, Anorexia complications, Anorexia therapy, Appetite, Frailty complications, Frailty diagnosis, Frailty etiology, Humans, Quality of Life, Syndrome, Aging physiology, Anorexia physiopathology, Sarcopenia diagnosis, Sarcopenia etiology, Sarcopenia therapy
- Abstract
Appetite loss/anorexia of aging is a highly prevalent and burdensome geriatric syndrome that strongly impairs the quality of life of older adults. Loss of appetite is associated with several clinical conditions, including comorbidities and other geriatric syndromes, such as frailty. Despite its importance, appetite loss has been under-evaluated and, consequently, under-diagnosed and under-treated in routine clinical care. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually on September 27th 2021 to debate issues related to appetite loss/anorexia of aging. In particular, topics related to the implementation and management of appetite loss in at-risk older adult populations, energy balance during aging, and the design of future clinical trials on this topic were discussed. Future actions in this field should focus on the systematic assessment of appetite in the care pathway of older people, such as the Integrated Care for Older People (ICOPE) program recommended by the World Health Organization. Moreover, clinical care should move from the assessment to the treatment of appetite loss/anorexia. Researchers continue to pursue their efforts to find out effective pharmacologic and non-pharmacologic interventions with a favorable risk/benefit ratio., Competing Interests: The Task Force was partially funded by registration fees from industrial participants. These corporations placed no restrictions on this work. Dr. Morley, Dr. Landi, Dr. Roberts, and Dr. Rolland declare no conflicts of interest related to this work; Dr de Souto Barreto reports consulting from Pfizer, outside the submitted work; Dr. Cederholm reports personal fees from Nutricia, personal fees from Abbott, personal fees from Fresenius Kabi, grants from Pfizer, outside the submitted work; Dr. Cesari reports personal fees from Nestlé Health Sciences, outside the submitted work; Dr. Vellas is an investigator in clinical trials sponsored by the Toulouse University Hospital (Inspire Geroscience Program); Dr Fielding reports grants from National Insitutes of Health, grants from USDA Agricultural Research Service, grants, personal fees and stock options from Axcella Health, stock options from Juvicell, stock options from Inside Tracker, grants and personal fees from Biophytis, personal fees from Amazentis, personal fees from Nestle, grants from Pfizer, outside the submitted work.
- Published
- 2022
- Full Text
- View/download PDF